Cvs Pharmacy #07110 | |
3633 Bunker Lake Blvd Nw, Andover, Minnesota 55304 | |
(763) 421-5011 |
Name | Cvs Pharmacy #07110 |
---|---|
Organization Name | Grand St Paul Cvs Llc |
Location | 3633 Bunker Lake Blvd Nw, Andover, Minnesota 55304 |
Type | Community/Retail Pharmacy |
Phone | (763) 421-5011 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma - the most aggressive kidney cancer.
Sixty-two per cent of Africans do not have access to an improved sanitation facility - a proper toilet - which separates human waste from human contact, according to the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
An international consortium of epidemilogists - including Dr. Alexandra Nieters and Professor Nikolaus Becker of the Clinical Epidemiology Division of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) - has conducted the first ever investigation of genetic factors in the development of non-Hodgkin's lymphoma (NHL) in a study called InterLymph.
› Verified 5 days ago
NPI Number | 1063016863 |
Type | Community/Retail Pharmacy |
Address | 3633 Bunker Lake Blvd Nw, Andover, MN 55304 |
Phone Number | 763-421-5011 |
News Archive
Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma - the most aggressive kidney cancer.
Sixty-two per cent of Africans do not have access to an improved sanitation facility - a proper toilet - which separates human waste from human contact, according to the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
An international consortium of epidemilogists - including Dr. Alexandra Nieters and Professor Nikolaus Becker of the Clinical Epidemiology Division of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) - has conducted the first ever investigation of genetic factors in the development of non-Hodgkin's lymphoma (NHL) in a study called InterLymph.
› Verified 5 days ago
NPI Number | 1427157726 |
Organization Name | GRAND ST PAUL CVS LLC |
Doing Business As | CVS PHARMACY #07110 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 3633 Bunker Lake Blvd Nw, Andover, MN 55304 |
Phone Number | 763-421-5011 |
News Archive
Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma - the most aggressive kidney cancer.
Sixty-two per cent of Africans do not have access to an improved sanitation facility - a proper toilet - which separates human waste from human contact, according to the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
An international consortium of epidemilogists - including Dr. Alexandra Nieters and Professor Nikolaus Becker of the Clinical Epidemiology Division of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) - has conducted the first ever investigation of genetic factors in the development of non-Hodgkin's lymphoma (NHL) in a study called InterLymph.
› Verified 5 days ago
News Archive
Mayo Clinic Cancer Center investigators report that imatinib mesylate (GleevecTM), the drug used to treat patients with gastrointestinal stromal cancers (GISTs), is not likely to be effective for patients with high grade renal cell carcinoma - the most aggressive kidney cancer.
Sixty-two per cent of Africans do not have access to an improved sanitation facility - a proper toilet - which separates human waste from human contact, according to the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation.
Magellan GPS announced today the launch of its first two products in its new fitness line: Switch and Switch Up. Designed to meet the needs of runners, cyclists, and multisport athletes, the new Switch Series is a powerful, adaptable, and customizable family of crossover GPS watches that will integrate seamlessly with third party sites.
Millions of people around the world lack access to clean drinking water, and experts predict the situation could get worse unless new solutions are implemented. A panel of scientists addressing the issue outlines strategies that could help curb this humanitarian crisis in a new white paper, "Chemistry and Water: Challenges and Solutions in a Changing World."
An international consortium of epidemilogists - including Dr. Alexandra Nieters and Professor Nikolaus Becker of the Clinical Epidemiology Division of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) - has conducted the first ever investigation of genetic factors in the development of non-Hodgkin's lymphoma (NHL) in a study called InterLymph.
› Verified 5 days ago
Cvs Pharmacy #07110 Type: Community/Retail Pharmacy Location: 3633 Bunker Lake Blvd Nw, Andover, Minnesota 55304 Phone: (763) 421-5011 | |
Cvs Pharmacy #17118 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2000 Bunker Lake Blvd Nw, Andover, Minnesota 55304 Phone: (763) 852-0114 | |
Walgreens #2078 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2134 Bunker Lake Blvd Nw, Andover, Minnesota 55304 Phone: (763) 754-6409 | |
Walmart Pharmacy 10-1999 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1851 Bunker Lake Blvd Nw, Andover, Minnesota 55304 Phone: (763) 354-5720 | |
Goodrich Pharmacy Andover Type: Pharmacy Location: 15245 Bluebird St Nw, Andover, Minnesota 55304 Phone: (763) 434-1901 |